Clinical Trials Directory

Trials / Completed

CompletedNCT03806712

Comprehensive Study of Social Representation of Platelet Transfusion in Patients Followed for Advanced Hematological Malignancies (R-PLQ)

Status
Completed
Phase
Study type
Observational
Enrollment
45 (actual)
Sponsor
Centre Hospitalier Universitaire de Besancon · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

Limited data is available for end of life care in hematologic malignancies, moreover with thrombocytopenic patients. Thrombopenia is a frequent complication, specific of bone marrow involvement in those diseases or its treatments. Yet, a few studies was interested in, whereas platelet transfusion is the only treatment indicated. As it represent a scarce, limited resource, the ethical principles are in conflict in this setting and there's a lack of recommendation. The final decision is take by the clinician and his patient, but no study exist in representation of the two parts. We provide a qualitative study to understand what this decision is made of.

Conditions

Interventions

TypeNameDescription
OTHERmulti method questionary (developped by De Rosa, in 1995 and 2014)questions from an association network according to the subject and the grounded theorise (Glasser and Strauss)

Timeline

Start date
2019-04-01
Primary completion
2019-06-01
Completion
2019-07-22
First posted
2019-01-16
Last updated
2019-07-25

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03806712. Inclusion in this directory is not an endorsement.